Information for "Advantageous tyrosine kinase chemical treatment in the affected person using relapsed BCRABL1like serious lymphoblastic leukemia together with CCDC88CPDGFRB blend"
Basic information
Display title | Advantageous tyrosine kinase chemical treatment in the affected person using relapsed BCRABL1like serious lymphoblastic leukemia together with CCDC88CPDGFRB blend |
Default sort key | Advantageous tyrosine kinase chemical treatment in the affected person using relapsed BCRABL1like serious lymphoblastic leukemia together with CCDC88CPDGFRB blend |
Page length (in bytes) | 3,672 |
Namespace ID | 0 |
Page ID | 359156 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Disallowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Diggerface25 (talk | contribs) |
Date of page creation | 10:11, 14 January 2024 |
Latest editor | Diggerface25 (talk | contribs) |
Date of latest edit | 10:11, 14 January 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 0 |
Recent number of distinct authors | 0 |